PBLS
Parabilis Medicines, Inc.
29.65
-0.37 (-1.23%)
52w low 22.66
42.49 high
35.2% of range
Financial Analysis
| (USD) | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Cash & Equivalents | 47.28M | 27.71M | |
| Receivables | 360.00K | 0.00 | |
| Current Assets | 92.21M | 29.36M | |
| Net PP&E | 52.93M | 46.08M | |
| Total Assets | 149.25M | 80.82M | |
| Current Liabilities | 32.41M | 56.79M | |
| Total Debt | 66.20M | 58.70M | |
| Total Liabilities | 92.81M | 97.34M | |
| Retained Earnings | -395.62M | -541.50M | |
| Shareholders Equity | 56.44M | -16.52M | |
| Working Capital | 59.80M | -27.43M | |
| Shares Outstanding | 118.15M | 118.15M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--